Skip to main content
. Author manuscript; available in PMC: 2021 Mar 15.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2019 Nov 29;106(4):790–799. doi: 10.1016/j.ijrobp.2019.11.028

Fig. 4.

Fig. 4.

Time to progression comparing patients with recurrent World Health Organization (WHO) grade II to those with initially diagnosed WHO grade III meningioma. The percentages accompanying the curves are annual actuarial results, from 1 to 5 years after study registration. Used with permission from NRG Oncology.